Business Wire

Battelle and Spark Biomedical, Inc. Join Forces to Advance Bioelectric Treatment Solutions for Opioid Use Disorder

DALLAS & COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle, the largest independent nonprofit applied science and technology organization in the world, and Spark Biomedical, Inc., a leading developer of ...
Business Wire

Spark Biomedical Taps AcuityMD to “Turbo-Charge” Efforts to Build New Market of Non-Invasive Therapeutics for Opioid Use Disorder

BOSTON--(BUSINESS WIRE)--Spark Biomedical, a leading developer of wearable neurostimulation solutions, has partnered with AcuityMD, a commercial platform for medical technology companies, to ...
Business Insider

Spark Biomedical Sets Sights on Global Expansion with New ISO 13485 and MDSAP Certifications

Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality ...
Business Insider

Spark Biomedical Appoints Anja Krammer as Chief Executive Officer to Accelerate Clinical and Commercial Growth

Dallas, TX, May 04, 2026 (GLOBE NEWSWIRE) -- Dallas, TX — May 04, 2026 — Spark Biomedical, a leader in bioelectronic medicine and non-invasive neuromodulation, today announced the appointment of Anja ...
Morningstar

Spark Biomedical Completes Enrollment for Pivotal Trial in Neonatal Opioid Withdrawal Treatment

Dallas, TX, March 24, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal phase II clinical trial, offering hope to ...
Seeking Alpha

electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal

ROCKAWAY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Sparrow Ascent™ by Spark ...
Benzinga.com

Spark Biomedical's second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in Adults

DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable neurostimulation development, is proud to announce that its next-generation, groundbreaking ...
EurekAlert!

University of Cincinnati, Spark Biomedical trial aims to increase treatment retention for patients with opioid use disorder and PTSD

The University of Cincinnati’s Center for Addiction Research and Spark Biomedical are conducting a clinical trial to help patients with opioid use disorder (OUD) and post-traumatic stress disorder ...